XNYS · DGX

-0.06% · -$0.1500 · Vol 576.5K

After hours · updated 19:00:00 ET

Quest Diagnostics Inc.

SERVICES-MEDICAL LABORATORIES

$238.35

Card

Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factors

Fri Aug 7 · session closed · Markets closed · resumes Mon 9:30 ET · DGX

Methodology

DGX

Quest Diagnostics Inc.

Fri Aug 7 · session closed · Markets closed · resumes Mon 9:30 ET

70/100

BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

70/ 100

Veridion Score

BUY BIAS · HIGH confidence

Sovereign · $25/mo

See why this score moved.

· Factor breakdown with raw signals
· Day-over-day delta + driver
· Factor coverage readout
· Valuation · hype · market flow
· Pro Chart event markers
· Score history + alerts

Start Sovereign · $25/mo →

Cancel anytime · or Reserve · $79/mo

Confidence: HIGH · 6/6 factors with data · Fri Aug 7 · session closed · Markets closed · resumes Mon 9:30 ET

Share on X →

Veridion Score History · 90D

AI Analysis

Sovereign

Why is DGX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move DGX next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Congress / Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Aug 7
Score
Score moved +25
45/NEUTRAL -> 70/BUY BIAS
Veridion score historySource
Mar 30
CongressChecking access
Alan Armstrong purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Mar 27
CongressChecking access
Alan Armstrong purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Feb 17
CongressChecking access
Ro Khanna sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jan 29
CongressChecking access
Ro Khanna purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Nov 3
CongressChecking access
Julie Johnson sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Jul 24
CongressChecking access
Julia Letlow sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Apr 28
CongressChecking access
Julia Letlow purchase disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access
Mar 10
CongressChecking access
Carol Devine Miller sale disclosed
Checking the receipt access included with your plan.
STOCK Act filingChecking access

About Quest Diagnostics Inc.

SERVICES-MEDICAL LABORATORIES

Listed since

1996

Employees

57K

Country

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$236.34

Day high

$239.38

Day low

$236.34

Previous close

$238.50

52W high

$239.38

-0.43% from high

52W low

$173.49

98% of range

Market cap

$26.3B

P/E

24.55×

EPS

$9.71

Beta

-0.36

Shares out

110.4M

Volume

576.5K

0.56× rel vol

Avg volume

VWAP

$238.34

Price history computed in-house

+2.29%

+14.48%

+27.19%

+36.77%

YTD

+37.35%

SMA 50 $211.09 · above

SMA 200 $195.24 · above

52W position 98%

DGX overview

Veridion Score

6 of 6 factors measured

Congress receipts

Alan Armstrong · Purchase

13F holders

None on file

Relationship mapTrace receipt-backed holders and filings around DGX.Congress disclosuresOpen receipt and filing context for DGX.MethodologyReview score inputs, coverage rules, and limitations.

SEC Form 4 ledger

DGX insider activity

Quest Diagnostics Inc.

Score

Not evaluated

Pressure

Not evaluated

Filings

Buys / sells

0 / 0

Net value

Not evaluated

Insiders

Cluster

Not covered: this ticker is outside our Form 4 ingest scope — we have not looked

Net pressure

Not evaluated: no value-bearing Form 4 rows are loaded.

Convergence not evaluated

No value-bearing Form 4 rows are loaded, so cross-source convergence is not evaluated.

No value-bearing Form 4 rows

The current Form 4 feed did not return value-bearing open-market rows for DGX.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Public disclosures

Congress activity in DGX

Congress tracker Open ticker disclosure ledger →

Alan ArmstrongBuyself

Quest Diagnostics Incorporated Common Stock · Transaction Mar 30, 2026 · Filed Jul 21, 2026 · $1,001 to $15,000

Official filing ↗

Alan ArmstrongBuyself

Quest Diagnostics Incorporated Common Stock · Transaction Mar 27, 2026 · Filed Jul 21, 2026 · $1,001 to $15,000

Official filing ↗

Ro KhannaSell

DGX Common Stock · Transaction Feb 17, 2026 · Filed Mar 9, 2026 · Amount pending receipt enrichment

Official filing ↗

Ro KhannaBuy

DGX Common Stock · Transaction Jan 29, 2026 · Filed Feb 6, 2026 · Amount pending receipt enrichment

Official filing ↗

Julie JohnsonSelljoint

Quest Diagnostics Incorporated Common Stock · Transaction Nov 3, 2025 · Filed Dec 11, 2025 · $1,001 to $15,000

Official filing ↗

Federal contracts

DGX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for DGX in this window.

Lobbying spend

DGX lobbying filings, year to date.

Registered lobbying filings matched to Quest Diagnostics Inc..

$2.2M

Refresh interval: 12hSource: LDA disclosure filings

Budget/Appropriations Health Issues Medicare/MedicaidHealth Issues Medicare/Medicaid Budget/AppropriationsHealth Issues Budget/Appropriations Medicare/Medicaid

Filing

$690.0K

QUEST DIAGNOSTICS INCORPORATED

Apr 20, 2026

Filing

$470.0K

QUEST DIAGNOSTICS INCORPORATED

Jul 20, 2026

Filing

$350.0K

QUEST DIAGNOSTICS INCORPORATED

Jan 20, 2026